Generic Drugs Market to see 11.02% CAGR Globally by 2018, says a Research Report available at Reports and Intelligence

Press release February 9, 2015 Generic Drugs Market 2014-2018 Generic Drugs Applications Generic Drugs Market Generic Drugs Market Size Generic Drugs Market Trends

Reports and Intelligence adds a report titled “Global Generic Drugs Market 2014-2018.”

Reports and Intelligence adds a report titled “Global Generic Drugs Market 2014-2018.” The report states that the global generic drugs market is expected to register a CAGR of 11.02% during the forecast period i.e. 2013-2018.

The increasing number of patent expiration is the major factor driving the growth of the global generic drugs market. The global market has also been witnessing a growing number of acquisition and mergers between the companies operating in the generic drugs market. However, the market still projects a stiff competitive landscape, which hampers the growth and affects the new entries in the global generic drugs market.

The report on the global generic drugs market consists of inputs from the industry experts, which would help the readers to evaluate the latest market trends and various other factors influencing the growth of the global generic drugs market.

Browse detailed report at: http://www.reportsandintelligence.com/global-generic-drugs-2014-2018-market

The study covers a wide range of geographical regions from all across the globe such as APAC, America and EMEA and provide detail analysis of the competitive landscape and growth prospects of the global generic drugs market.

Companies profiled in the report are Actavis plc, Mylan Inc., Novartis International AG (Sandoz), STADA Arzneimittel AG, Teva Pharmaceutical Industries Ltd., 3SBio Inc., Amgen Inc., Apotex Inc., AstraZeneca plc, Aurobindo Pharma Ltd., Baxter International Inc., Berlin-Chemie AG, Biocon Ltd., Biogen Idec Inc., Boehringer Ingelheim GmbH, Celltrion Inc., Cipla Ltd., Coherus Biosciences Inc., Daiichi Sankyo Co. Ltd., Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Ltd., Gedeon Richter plc, GlaxoSmithKline plc, Hospira Inc., Impax Laboratories Inc., Intas Pharmaceuticals Ltd., Lupin Ltd., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corp., Par Pharmaceutical Inc., Pfizer Inc., Ranbaxy Laboratories Ltd., Roche Holding AG, Sanofi S.A., Wockhardt Ltd., and Zydus Cadila Healthcare Ltd.

Key questions answered in this report:
What will the market size and growth rate be in 2018?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

Contact Us:
Deep Joshi
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States

Direct: +1 (617) 674-4143
Toll Free: +1 (855) 711-1555
Fax: +1 (855) 550-5975
Email us: [email protected]
Web: http://www.reportsandintelligence.com
LinkedIn: https://www.linkedin.com/company/reports-and-intelligence

Subjects

---

Generic Drugs Market 2014-2018 Generic Drugs Applications Generic Drugs Market Generic Drugs Market Size Generic Drugs Market Trends